A selective MEK1/2 inhibitor for studying MAPK/ERK signaling and cancer-related cellular responses.
Selleck AZD6244, also known as Selumetinib, is a selective MEK1/2 inhibitor that suppresses ERK1/2 phosphorylation. It is commonly used in cancer biology, MAPK pathway research, cell-proliferation studies and apoptosis experiments.
Brand: Selleck Chemicals
Catalog number: S1008
Primary targets: MEK1 and MEK2
Synonym: Selumetinib
CAS number: 606143-52-6
Product type: MAPK pathway inhibitor
Official product link: AZD6244 (Selumetinib) – S1008
